Indium-111-capromab pendetide scans: an important test relevant to clinical decision making.
Sartor
O
O
Stanley S. Scott Cancer Center and Department of Medicine, Louisiana State University Medical School, New Orleans, Louisiana 70112, USA .
McLeod
D
D
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D002268:Carboxypeptidases / Q000276:immunology; D003657:Decision Making; D043425:Glutamate Carboxypeptidase II; D006801:Humans; D007205:Indium Radioisotopes; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000032:analysis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000556:secondary; D011877:Radionuclide Imaging
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D007205:Indium Radioisotopes; C101315:Capromab Pendetide; D002268:Carboxypeptidases; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II; D017430:Prostate-Specific Antigen